CoChat

Physiologically-based pharmacokinetic simulation modelling

Grass, George M, Sinko, Patrick J · 2002 · Advanced Drug Delivery Reviews

The DOI matches its Crossref record; 111 of the 115 references it cites were found in a registry or an index.

Abstract

Drug selection is now widely viewed as an important and relatively new, yet largely unsolved, bottleneck in the drug discovery and development process. In order to achieve an efficient selection process, high quality, rapid, predictive and correlative ADME models are required in order for them to be confidently used to support critical financial decisions. Systems that can be relied upon to accurately predict performance in humans have not existed, and decisions have been made using tools whose capabilities could not be verified until candidates went to clinical trial, leading to the high failure rates historically observed. However, with the sequencing of the human genome, advances in proteomics, the anticipation of the identification of a vastly greater number of potential targets for drug discovery, and the potential of pharmacogenomics to require individualized evaluation of drug kinetics as well as drug effects, there is an urgent need for rapid and accurately computed pharmacokinetic properties.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0169-409x(02)00013-3

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 111 references

Research works printed but not linked: 9

  1. Peakman, 2001, Putting the code to work: The promise of pharmacogenetics and pharmacogenomics, Drug Discovery World, 2, 35
  2. PhRMA. Why do drugs cost so much? PhRMA, Washington DC, 2000, pp. 1–22.
  3. Leahy, 1997, Pharmacokinetics in early drug research, ATLA, 25, 17
  4. Dearden, 1984, Mathematical modelling of the drug transport process— incorporation of realistic transfer rate constants and a dissolution step QSAR and strategies in the design of bioactive compounds, Pharm. Res., 1, 328
  5. A. Regalado. Re-engineering drug development 1: Simulating clinical trials, Start-up, Windover Information Inc., Vol. January, 1998, pp. 13–18.
  6. Sale, 2001, Modelling and simulation in drug development, promise and reality, Drug Discov. World, 2, 47
  7. Brodie, 1964, Of mice, microsomes, and men, Pharmacologist, 6, 12
  8. Pickering, 2001, Creating a pharmacological profile, Drug Disc. and Dev., 4, 53
  9. Lindpaintner, 2001, Pharmacogenetics: A review of concepts and contents, Drug Discovery World, 2, 21

Cited by

See all 174

Metadata

Authors
Grass, G. M., & Sinko, P. J.
Affiliations
Rutgers, The State University of New Jersey (US)
Corresponding author
Grass, George M
Venue
Advanced Drug Delivery Reviews
Publisher
Elsevier BV
Published
2002-03
Volume
54
Issue
3
Pages
433-451
ISSN
0169-409X (ISSN-L)
OpenAlex
W1979813244
Cited by
160
References
115
Citations by year
2026: 2 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2020: 6 · 2019: 7 · 2018: 7 · 2017: 4 · 2016: 9 · 2015: 4 · 2014: 7 · 2013: 10 · 2012: 5
FWCI
1.01
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Advanced Drug Delivery Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
physiologically based pharmacokinetic modelling, ADME prediction, drug selection, drug discovery, drug development, pharmacogenomics, drug target identification
MeSH terms
Animals, Computer Simulation, Drug Industry, Pharmaceutical Preparations, Humans, Models, Biological, Pharmacokinetics, Computational Biology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Physiologically-based pharmacokinetic simulation modelling. https://app.cochat.ai/papers/10.1016/s0169-409x(02)00013-3
The paper
Grass, G. M., & Sinko, P. J. (2002). Physiologically-based pharmacokinetic simulation modelling. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(02)00013-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.